Johnson & Johnson to Resume Manufacturing of Cosmetics at the Mulund Plant

MUMBAI, September 24, 2013 /PRNewswire/ --

The Bombay High Court today allowed baby products manufacturer Johnson & Johnson to restart the manufacturing of baby powder at its Mulund unit, which had been stopped upon the order of Maharashtra Food and Drug Administration.

The Honourable High Court passed this judgment after due consideration of all facts related to the case. The court also found the company's offer to test the batches of baby powder in question, reasonable. Further, there was no scientific foundation that there were any carcinogens present in that batch of baby powder.

"Nothing is more important to us than the well-being of consumers, and we see this outcome as a significant step in restoring their confidence. We will continue to work closely with Maharashtra FDA, and provide India with safe, high quality products that help people care for themselves and their families," said a Johnson & Johnson, India spokesperson.

For the past 100 years, Johnson & Johnson has earned the trust of over one billion families and healthcare professionals. Our commitment to safety and health of our consumers has and will always be, our top priority.

About Johnson's® Baby:

With a legacy of over 100 years, Johnson's® Baby is a market leader in its category, driving the trends and developments in the baby space. Johnson's® Baby aspires to touch every baby in India with brands operating in the widest consumer spectrum. From premium products like Johnson's® Baby Top-To-Toe® Wash - the first ever liquid bath product for babies, Johnson's® Baby Skincare Wipes to low cost outlay packs of soaps and powders that are more accessible to consumers at the bottom of the pyramid, Johnson's® Baby's offerings cover an entire range.

Primary Media Contact: Ransom DSouza, [email protected], 91-9820234999

Secondary Media Contact: Romil Zaveri, [email protected], 91-9819423527